Terms: = Colorectal cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
100 results:
1. Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
Ben-Yaacov A; Levine O; Schtrechman G; Adileh M; Beller T; Boursi B; Halpern N; Goldstein A; Ben-Yakov G; Nissan A; Laks S
World J Surg; 2024 Apr; 48(4):871-878. PubMed ID: 38686748
[TBL] [Abstract] [Full Text] [Related]
2. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
[TBL] [Abstract] [Full Text] [Related]
3. Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
van de Vlasakker VCJ; Guchelaar NAD; van den Heuvel TBM; Lurvink RJ; van Meerten E; Bax RJF; Creemers GM; van Hellemond IEG; Brandt-Kerkhof ARM; Madsen EVE; Nederend J; Koolen SLW; Nienhuijs SW; Kranenburg O; de Hingh IHJT; Verhoef C; Mathijssen RHJ; Burger JWA; ;
BMJ Open; 2024 Jan; 14(1):e077667. PubMed ID: 38238055
[TBL] [Abstract] [Full Text] [Related]
4. Impact of prognostic nutritional index change on prognosis after colorectal cancer surgery under propofol or sevoflurane anesthesia.
Zhang L; Liu C; Yan Q; Cai X
BMC Anesthesiol; 2024 Jan; 24(1):12. PubMed ID: 38172695
[TBL] [Abstract] [Full Text] [Related]
5. Is Precision Surgery Applicable to colorectal Liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor Biology.
Pikoulis E; Papaconstantinou D; Pikouli A; Pararas N; Buettner S; Wang J; Stasinos G; Belias M; Dellaportas D; Pozios I; Antoniou E; Beyer K; Kreis ME; Pawlik TM; Margonis GA
Ann Surg Oncol; 2024 Mar; 31(3):1823-1832. PubMed ID: 38155339
[TBL] [Abstract] [Full Text] [Related]
6. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Desai J; Alonso G; Kim SH; Cervantes A; Karasic T; Medina L; Shacham-Shmueli E; Cosman R; Falcon A; Gort E; Guren T; Massarelli E; Miller WH; Paz-Ares L; Prenen H; Amatu A; Cremolini C; Kim TW; Moreno V; Ou SI; Passardi A; Sacher A; Santoro A; Stec R; Ulahannan S; Arbour K; Lorusso P; Luo J; Patel MR; Choi Y; Shi Z; Mandlekar S; Lin MT; Royer-Joo S; Chang J; Jun T; Dharia NV; Schutzman JL; ; Han SW
Nat Med; 2024 Jan; 30(1):271-278. PubMed ID: 38052910
[TBL] [Abstract] [Full Text] [Related]
7. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
8. Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases.
Liao L; Sun H; He J; Liu Y; Pan Z; Wu X; Fan W; Peng J; Li C
BMC Surg; 2023 Sep; 23(1):271. PubMed ID: 37689651
[TBL] [Abstract] [Full Text] [Related]
9. Impact of Pattern Recognition Receptors on the prognosis of Chemotherapy-treated Rectal cancer Patients.
Chang CL; Huang KC; Chen TW; Chen WT; Ke TW; Liou YF; Chao KSC; Chiang SF
In Vivo; 2023; 37(4):1552-1561. PubMed ID: 37369459
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of Systemic Treatments of Small Intestinal Adenocarcinomas: A Systematic Review and Meta-analysis.
de Back T; Nijskens I; Schafrat P; Chalabi M; Kazemier G; Vermeulen L; Sommeijer D
JAMA Netw Open; 2023 Feb; 6(2):e230631. PubMed ID: 36826817
[TBL] [Abstract] [Full Text] [Related]
11. Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative.
Beal EW; Srinivas S; Shen C; Kim A; Johnston FM; Greer J; Abbott DE; Pokrzywa C; Raoof M; Grotz TE; Leiting JL; Fournier K; Dineen S; Powers B; Veerapong J; Kothari A; Maduekew U; Maithel S; Wilson GC; Patel SH; Lambert L; Abdel-Misih S; Cloyd JM
Ann Surg Oncol; 2023 Mar; 30(3):1840-1849. PubMed ID: 36310315
[TBL] [Abstract] [Full Text] [Related]
12. Long-Term Clinical Outcomes of Patients with colorectal cancer with Metastatic Epidural Spinal Cord Compression Treated with Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy).
Chakravarthy VB; Schachner B; Amin A; Reiner AS; Yamada Y; Schmitt A; Higginson DS; Laufer I; Bilsky MH; Barzilai O
World Neurosurg; 2023 Jan; 169():e89-e95. PubMed ID: 36272727
[TBL] [Abstract] [Full Text] [Related]
13. A genetic map of the chromatin regulators to drug response in cancer cells.
Chen B; Li P; Liu M; Liu K; Zou M; Geng Y; Zhuang S; Xu H; Wang L; Chen T; Li Y; Zhao Z; Qi L; Gu Y
J Transl Med; 2022 Sep; 20(1):438. PubMed ID: 36180906
[TBL] [Abstract] [Full Text] [Related]
14. Current cancer burden in China: epidemiology, etiology, and prevention.
Maomao C; He L; Dianqin S; Siyi H; Xinxin Y; Fan Y; Shaoli Z; Changfa X; Lin L; Ji P; Wanqing C
Cancer Biol Med; 2022 Aug; 19(8):1121-38. PubMed ID: 36069534
[TBL] [Abstract] [Full Text] [Related]
15. Effect of E-cadherin on prognosis of colorectal cancer: A Meta-Analysis Update.
Chang K; Jiang L; Sun Y; Li H
Mol Diagn Ther; 2022 Jul; 26(4):397-409. PubMed ID: 35732878
[TBL] [Abstract] [Full Text] [Related]
16. Does Preoperative Waiting Time Affect the Short-Term Outcomes and prognosis of colorectal cancer Patients? A Retrospective Study from the West of China.
Liu XY; Li ZW; Kang B; Cheng YX; Tao W; Zhang B; Zhang H; Wei ZQ; Peng D
Can J Gastroenterol Hepatol; 2022; 2022():8235736. PubMed ID: 35535032
[TBL] [Abstract] [Full Text] [Related]
17. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative functional capacity and postoperative outcomes following abdominal and pelvic cancer surgery: a systematic review and meta-analysis.
Makker PGS; Koh CE; Solomon MJ; Steffens D
ANZ J Surg; 2022 Jul; 92(7-8):1658-1667. PubMed ID: 35253333
[TBL] [Abstract] [Full Text] [Related]
19. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
[TBL] [Abstract] [Full Text] [Related]
20. Quality Assessment of Online Resources for the Most Common cancers.
Li JZH; Kong T; Killow V; Wang L; Kobes K; Tekian A; Ingledew PA
J Cancer Educ; 2023 Feb; 38(1):34-41. PubMed ID: 34365589
[TBL] [Abstract] [Full Text] [Related]
[Next]
